Author - Axis Consulting

Scotland: setting the tone for Patient-Centric Reimbursement Decision making

The effect Brexit is likely to have on medicine reimbursement timelines is prompting some market access experts to think more carefully about the strategy for future submissions. As I discussed in a previous blog, One Size Doesn’t Fit All, typically companies submit to the National Institute for Health and Care Excellence (NICE), followed by a submission to the Scottish Medicines Consortium (SMC), and then turn their attention to submitting...

ABPI Scottish Global Showcase 2021

Professor Sir Mike Ferguson, Dundee University: Who will present opportunities from his university targeting companies’ internal angel funds/ venture funding along with other opportunities. It would be a rare R&D person who would not want the opportunity of hearing from one of the UK’s scientists.
CONTACT US